The mortality rate of intracranial infections is relatively low if timely anti-infective treatment is administered; however, the mortality rate is higher if the infection spreads without timely treatment, but authoritative mortality data are lacking.
Intracranial infections are neurological lesions caused by various pathogens invading the intracranial brain parenchyma, meninges and blood vessels, including encephalitis and meningitis, etc., which usually lead to different degrees of neurological impairment in patients after infection.
Therefore, in the absence of effective anti-infective treatment, intracranial infections cause a high mortality rate and are more detrimental to healthy life expectancy.
In the case of intracranial infection or possible tendency to intracranial infection, timely administration of anti-infective drugs for targeted prevention or treatment can effectively reduce the probability of intracranial infection and lower mortality.
Viral infections can be treated with antiviral drugs such as acyclovir and ribavirin. For fungal infections, drugs such as clotrimazole and ketoconazole can be used.
In the event of intracranial infections or possible intracranial infections, appropriate medications should be selected for prevention or treatment under the guidance of a physician.